Dyne Therapeutics, Inc.
DYNNASDAQHealthcare● Active
$16.81
$-0.23(-1.35%)
Market Cap$2.8B
P/E Ratio—
52W High$25
52W Low$8.06
Dyne Therapeutics, Inc.（DYN）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DYN · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $1.11B | $0.64B | $0.12B | $0.26B | $0.38B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $1.13B | $0.66B | $0.13B | $0.27B | $0.38B |
| PP&E Net | $0.04B | $0.03B | $0.03B | $0.04B | $0.04B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $1.19B | $0.69B | $0.17B | $0.31B | $0.43B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.02B | $0.01B | $0.00B |
| Total Current Liabilities | $0.05B | $0.04B | $0.05B | $0.03B | $0.03B |
| Long-Term Debt | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.21B | $0.06B | $0.07B | $0.05B | $0.06B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.40B) | ($0.95B) | ($0.63B) | ($0.40B) | ($0.23B) |
| Total Stockholders Equity | $0.97B | $0.63B | $0.09B | $0.25B | $0.37B |
| Total Liab & Equity(computed) | $1.19B | $0.69B | $0.17B | $0.31B | $0.43B |
| Debt Summary | |||||
| Total Debt | $0.02B | $0.02B | $0.03B | $0.03B | $0.03B |
| Net Debt | ($0.87B) | ($0.41B) | ($0.09B) | ($0.14B) | ($0.17B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Dyne Therapeutics, Inc.
关于Dyne Therapeutics, Inc.（DYN）资产负债表
Dyne Therapeutics, Inc.总资产$1.19B，现金及短期投资$1.11B，总负债$0.21B，总债务$0.02B，股东权益$0.97B。
常见问题
DYN · 4 问Dyne Therapeutics, Inc.总债务$0.02B，净债务($0.87B)。
DYN total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10